Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,580.06
(
0.22%
)
US TECH 100
29,506.00
(
0.28%
)
Dow Jones
51,032.46
(
0.72%
)
Brent Oil
91.36
(
0.00%
)
Bitcoin
73,904.99
(
0.20%
)
News Focus
News Focus
Post# of 518959
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Investor2014

Send PM Follow Ignore
Followers 65
Posts 27906
Boards Moderated 0
Alias Born 11/23/2016

Investor2014

Re: boi568 post# 359528

Friday, 05/06/2022 4:57:47 PM

Friday, May 06, 2022 4:57:47 PM

Post# of 518959
Cons are one open label AD P2 trial with really small posthoc analysis subgroups and a theoretical correlation between a PDD and AD scoring system.

From that we can infer some numbers none of which are terrible reliable despite being encouraging.

We really won’t know with any certainty beyond a coin toss until the fat lady sings.
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent AVXL News
More AVXL News